Ironwood Pharmaceuticals | IRWD - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Almirall EUR 114.07M 60.37M 2025-12
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD -9.78M 19.98M 2026-06
Astellas Pharma JPY 235.24B 136.32B 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Charles River Laboratories USD 272.95M 43.14M 2026-06
Coherus Biosciences USD -43.33M 4.7M 2025-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -64.54M 34.34M 2026-06
Moderna USD -1.26B 468M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 48.67M 8.43M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Takeda JPY 369.75B 5.29B 2026-09
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12